FFTY

Fund Description
Innovator IBD 50 ETF is an exchange-traded fund actively managed and will generally hold all of the companies included in the IBD 50 Index other than during periods when the Fund is rebalanced due to changes in the constitution of the IBD 50 Index. The Fund will not invest in the IBD 50 Index companies in the same proportion as reflected in the Index. Innovator IBD 50 ETF invests in the Top 50 growth stocks as selected by IBD.
Fund Profile
Fund Name Innovator IBD 50 ETF
Fund Exchange Ticker FFTY
Fund Sponsor Innovator Management
Fund ISIN US45782C1027
Net Expense Ratio 0.80 %
Fund Inception Date 9 April 2015
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Factor & Thematic
Asset Class Equities (Stocks)
Index Linked Passive
Index Name IBD 50 Index
Index Provider IBD
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Growth
Continent North America
Key Statistics
Return As of Date 7 August 2020
Asset Under Management 237.22 Million (USD)
1 Month Total Return 3.52 %
Year To Date Return 8.47 %
1 Year Total Return 7.97 %
3 Year Annualized Total Return 8.56 %
NAV 37.6546
Share Outstanding 6,300,000
Top 10 Holdings (7 August 2020)
Constituent Name Constituent Ticker Constituent Type Weighting
PALOMAR HOLDINGS INC PLMR EQUI 0.0367000000
PENNYMAC FINL SVCS INC NEW PFSI EQUI 0.0365000000
WEST PHARMACEUTICAL SERVICES WST EQUI 0.0353000000
ADVANCED MICRO DEVICES AMD EQUI 0.0352000000
NVIDIA CORP NVDA EQUI 0.0351000000
FOCUS FINANCIAL PARTNERS-A FOCS EQUI 0.0350000000
PAYPAL HOLDINGS INC PYPL EQUI 0.0347000000
EMERGENT BIOSOLUTIONS INC EBS EQUI 0.0344000000
TERADYNE INC TER EQUI 0.0342000000
VEEVA SYS INC VEEV EQUI 0.0340000000